AzTrials
AzTrials

Cognitive ChangeNCT04703296

Mindfulness Training in Special Operations Forces (SOF) Candidates

A study testing MBAT course in people with Cognitive Change, run by University of Miami at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overarching goal of this study is to develop, deliver, and investigate the utility and feasibility of train-the-trainer delivery of mindfulness training (MT) in support of improved readiness (across cognitive, affective, and social domains of the human dimension) and improve retention of candidates in the SOF… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Cognitive Change
What is being tested?
MBAT course
Could I receive a placebo?
No, everyone receives an active treatment
How many people
245 participants
Where
1 siteUnited States
Study dates
16 Mar 2022to 9 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals who are between 18 and 65 years of age.
  • Individuals who are fluent English speakers.
  • Individuals who are active-duty service members.
  • Men and women of all races and ethnicities.
  • Individuals who are willing and able to consent to participate in the study.
  • Individuals who are attending Special Warfare Center and School (SWCS).

Who cannot join

  • Individuals who have a medical or neurological condition that might interfere with performance on the task in the study (e.g., epilepsy)
  • Individuals with a history of hospitalization for psychological/mental health issues within the last 6 months.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Miami

    Coral Gables, Florida, 33146

Other trials in United States

About this study

The overarching goal of this study is to develop, deliver, and investigate the utility and feasibility of train-the-trainer delivery of mindfulness training (MT) in support of improved readiness (across cognitive, affective, and social domains of the human dimension) and improve retention of candidates in the SOF qualification pipeline at the U.S. Army John F. Kennedy Special Warfare Center and School (referred to as SWCS).

Being tested
MBAT course
Keywords
Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MBAT courseBehavioural

    The MBAT will involve:

    (i) 4 weekly 1.5-hour course sessions. The sessions will provide guided exercises, didactic information, and discussions to promote greater mindfulness.

    (ii) Daily mindfulness practice that will be facilitated by the Measuring Mindfulness App (MMA) and/or instructor-delivered mindfulness practices. The daily mindfulness practice will require about 15 minutes to complete.

Study groups in NCT04703296
Study groupRoleWhat they receive
Mindfulness training (MT) groupExperimentalReceives 4 weeks of mindfulness training followed by a testing session.
Receives: Behavioral: MBAT course
No-training control (NTC) groupNo interventionReceives 4 weeks of no mindfulness training followed by a testing session.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Attentional Performance

    Attentional Performance as measured by the Sustained Attention Response Task (SART). SART has a range of scores from 0 to 1 with a higher score indicating better accuracy of completing the task.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  2. Change in Working Memory Performance

    Working Memory Performance as measured by the Working Memory Task with Affective Distracters (WMDA). WMDA has a range of scores from 0 to 100%, with higher scores indicating better accuracy on the task.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  3. Change in Cognitive Failures

    Cognitive Failures will be measured by the Cognitive Failures Questionnaire (CFQ). CFQ has total score ranging from 0 to 100, with a higher score indicating more cognitive failures.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

Secondary outcomes (6)
  1. Change in Positive Affect

    Positive Affect will be measured by the Positive and Negative Affect Schedule (PANAS-10). The PANAS Positive has a range of scores from 5 to 25, with higher score indicating higher positive mood.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  2. Change in Negative Affect

    Negative Affect will be measured by the Positive and Negative Affect Schedule (PANAS-10). The PANAS Negative has a range of scores from 5 to 25, with higher score indicating higher negative mood.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  3. Change in Perceived Stress

    The short version of the Perceived Stress Scale (PSS) will be used assess perceived stress. The 4-item PSS has a range of scores from 0 to 16, with higher score indicating higher level of perceived stress.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  4. Change in Psychological Health

    Patient Health Questionnaire (PHQ-4) will be used to assess depression and anxiety. PHQ-4 has a range of scores from 0 to 12, with higher scores indicating higher level of depression and anxiety.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  5. Change in Decentering

    EQ Decentering is an 11-item sub-scale measuring various thoughts and experiences, and the tendency to distance from those. The decentering score ranges from 1 to 55, with a higher score indicating high level of decentering.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

  6. Change in Mind Wandering

    Four Factor Mind Wandering (4FMW) Questionnaire is a 16-item scale that asks participants to indicate how often they experience a situation described in the form of a statement on a 5-point Likert-type scale from never (1) to always (5). 4FMW has a range of scores from 16 to 80, with higher scores indicating greater mind wandering.

    Measured: Baseline (week 1) to week 6 (after 4-week training interval)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2021
  2. Study start16 Mar 2022
  3. Primary completion7 Dec 2022
  4. Study completion9 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
245 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04703296
Sponsor's protocol ID
20201488
Other IDs
W81XWH20C0065
Status last verified
Jan 2023
First submitted
7 Jan 2021
Last updated
12 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MBAT course in people with Cognitive Change, run by University of Miami at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Attentional Performance (time frame: Baseline (week 1) to week 6 (after 4-week training interval)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in